Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
14.19
-0.42 (-2.87%)
At close: Dec 31, 2025, 4:00 PM EST
14.16
-0.03 (-0.21%)
After-hours: Dec 31, 2025, 5:57 PM EST
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 13 analysts that cover Acadia Healthcare Company stock have a consensus rating of "Buy" and an average price target of $24, which forecasts a 69.13% increase in the stock price over the next year. The lowest target is $13 and the highest is $66.
Price Target: $24 (+69.13%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Acadia Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 2 | 3 | 3 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +19.80% | Dec 18, 2025 |
| Barclays | Barclays | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | -1.34% | Dec 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +33.90% | Dec 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +19.80% | Dec 3, 2025 |
| Keybanc | Keybanc | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +76.18% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
3.36B
from 3.15B
Increased by 6.50%
Revenue Next Year
3.51B
from 3.36B
Increased by 4.38%
EPS This Year
2.20
from 2.78
Decreased by -20.91%
EPS Next Year
2.07
from 2.20
Decreased by -5.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.7B | |||
| Avg | 3.4B | 3.5B | |||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 8.9% | |||
| Avg | 6.5% | 4.4% | |||
| Low | 1.9% | -2.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.52 | 2.57 | |||
| Avg | 2.20 | 2.07 | |||
| Low | 1.90 | 1.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -9.4% | 17.0% | |||
| Avg | -20.9% | -6.0% | |||
| Low | -31.6% | -32.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.